Day: June 18, 2025

The annual general meeting of Icelandic Salmon AS (the “Company”) was held on 18 June 2025 at 11:00 (CEST). All resolutions were approved as proposed by the board. Please find the minutes including appendices enclosed. The documents are also made available on the Company’s website https://arnarlax.is/investors/. For more information, please contact: Björn Hembre, CEO. Tel: +47 913 47 432 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentAGM Minutes 2025 – Icelandic Salmon AS

MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce that its Chief Executive Officer, Lance Alstodt, will be interviewed during the Benzinga All-Access Show today, Wednesday, June 18, 2025, at 10:50 a.m. Eastern time. Benzinga All-Access Show Date: Wednesday, June 18, 2025 Time: 10:50 a.m. Eastern Time Live Webcast: https://youtube.com/live/VaTuqmybnfY?feature=share The interview will also be archived on the Investors section of the Company’s website. About BioRestorative Therapies, Inc. BioRestorative (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Company”) is pleased to announce that it has closed its previously announced and upsized underwritten public offering of common shares in the capital of the Company (the “Shares”) at a price of $13.35 per Share, including the full exercise of the over-allotment option, for aggregate gross proceeds of approximately $143,750,000 (the “Offering”). Desjardins Capital Markets acted as sole bookrunner, along with National Bank Financial Inc. and BMO Capital Markets as co-lead underwriters, with a syndicate of underwriters comprised of CIBC World Markets Inc., Raymond James Ltd., Stifel Nicolaus Canada Inc., Scotia Capital Inc.,...

New York, June 18, 2025 (GLOBE NEWSWIRE) — Eureka Acquisition Corp (the “Company”) (Nasdaq: EURK), a blank check company, today announced that its previously announced extraordinary general meeting in lieu of an annual general meeting of shareholders (the “Extraordinary General Meeting”) will be postponed from 9:00 a.m. Eastern Time on June 20, 2025 to 9:00 a.m. Eastern Time on June 25, 2025 (the “Postponement”) to allow the Company additional time to engage with shareholders.  The Extraordinary General Meeting is to be held for the purpose of considering and voting on, among other proposals, a proposal to amend the Company’s current charter to provide that the Company has until July 3, 2025 to complete a business combination and may elect to extend up to twelve times, each by a one-month extension, for a total of up to twelve...

Joint clients can now unify data and apply analytics that inform deal-related decision-making and improve business outcomes PALO ALTO, Calif., June 18, 2025 (GLOBE NEWSWIRE) — Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, today announced a new strategic collaboration with Snowflake, the AI Data Cloud company. Intapp client firms will now be able to quickly build and apply analytics across a broad set of firmwide data in the Snowflake AI Data Cloud, then leverage that information within Intapp DealCloud to further enrich their deal management capabilities.   This collaboration brings together Snowflake’s ability to combine data across key systems and DealCloud’s robust deal management capabilities which are underpinned by AI-powered workflows...

Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of immune system through multiple mechanisms India represents a key territory with a rapidly growing incidence rate of cancer cases, projected to increase to 2.08 million by 20401 BOSTON and LONDON, June 18, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced the Intellectual Property India (IPI) has issued Patent No. 562,919 titled, “Thailanstatin Analogs”. The issued patent covers claims for the Company’s potent immuno-oncology PH1 payload, proprietary non-cleavable and cleavable linkers and ADC technology which has applications across...

–  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy’s ~$40B Bitcoin holdings and Metaplanet’s meteoric treasury transformation –  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced it has become the first healthcare company to establish a Bitcoin treasury, completing a $20 million Bitcoin purchase of 187.42 BTC at an average price of $106,712 per Bitcoin via a Kraken custody account. Concurrent with this groundbreaking treasury strategy, Prenetics announced...